Syra Health Corp. Class A Common Stock Statistics
Share Statistics
Syra Health Corp. Class A Common Stock has 9.81M shares outstanding. The number of shares has increased by null% in one year.
Shares Outstanding | 9.81M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Institutions (%) | n/a |
Shares Floating | - |
Failed to Deliver (FTD) Shares | 1.99K |
FTD / Avg. Volume | 1.05% |
Short Selling Information
The latest short interest is 166.60K, so 1.7% of the outstanding shares have been sold short.
Short Interest | 166.60K |
Short % of Shares Out | 1.7% |
Short % of Float | 2.05% |
Short Ratio (days to cover) | 1.19 |
Valuation Ratios
The PE ratio is -1.69 and the forward PE ratio is -1.34.
PE Ratio | -1.69 |
Forward PE | -1.34 |
PS Ratio | 0.9 |
Forward PS | null |
PB Ratio | 1.23 |
P/FCF Ratio | -1.79 |
PEG Ratio | n/a |
Enterprise Valuation
Syra Health Corp. Class A Common Stock has an Enterprise Value (EV) of -.
EV / Earnings | null |
EV / Sales | null |
EV / EBITDA | null |
EV / EBIT | null |
EV / FCF | null |
Financial Position
The company has a current ratio of 5.25, with a Debt / Equity ratio of 0.06.
Current Ratio | 5.25 |
Quick Ratio | 5.25 |
Debt / Equity | 0.06 |
Total Debt / Capitalization | 5.82 |
Cash Flow / Debt | -11.12 |
Interest Coverage | -53.79 |
Financial Efficiency
Return on equity (ROE) is -0.73% and return on capital (ROIC) is -67.76%.
Return on Equity (ROE) | -0.73% |
Return on Assets (ROA) | -0.6% |
Return on Capital (ROIC) | -67.76% |
Revenue Per Employee | 70.71K |
Profits Per Employee | -37.67K |
Employee Count | 78 |
Asset Turnover | 1.12 |
Inventory Turnover | 0 |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -64.04% in the last 52 weeks. The beta is 0, so Syra Health Corp. Class A Common Stock's price volatility has been lower than the market average.
Beta | 0 |
52-Week Price Change | -64.04% |
50-Day Moving Average | 0.4 |
200-Day Moving Average | 1.06 |
Relative Strength Index (RSI) | 46.27 |
Average Volume (20 Days) | 189.78K |
Income Statement
In the last 12 months, Syra Health Corp. Class A Common Stock had revenue of $5.52M and earned -$2.94M in profits. Earnings per share was $-0.6.
Revenue | 5.52M |
Gross Profit | 1.41M |
Operating Income | -2.89M |
Net Income | -2.94M |
EBITDA | -2.84M |
EBIT | -2.89M |
Earnings Per Share (EPS) | -0.6 |
Balance Sheet
The company has $3.28M in cash and $248.10K in debt, giving a net cash position of $3.03M.
Cash & Cash Equivalents | 3.28M |
Total Debt | 248.10K |
Net Cash | 3.03M |
Retained Earnings | -5.06M |
Total Assets | 4.43M |
Working Capital | 3.19M |
Cash Flow
In the last 12 months, operating cash flow was -$2.76M and capital expenditures -$15.25K, giving a free cash flow of -$2.77M.
Operating Cash Flow | -2.76M |
Capital Expenditures | -15.25K |
Free Cash Flow | -2.77M |
FCF Per Share | -0.57 |
Margins
Gross margin is 25.6%, with operating and profit margins of -52.36% and -53.28%.
Gross Margin | 25.6% |
Operating Margin | -52.36% |
Pretax Margin | -53.28% |
Profit Margin | -53.28% |
EBITDA Margin | -51.42% |
EBIT Margin | -52.36% |
FCF Margin | -50.3% |
Dividends & Yields
SYRA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -146.34% |
FCF Yield | -69.54% |
Analyst Forecast
Currently there are no analyst rating for SYRA.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Scores
Altman Z-Score | -1.04 |
Piotroski F-Score | 2 |